SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending as the community celebrates the FDA approval of BYSANTI for schizophrenia and bipolar I disorder, anticipating a significant stock re-rating and potential for a short squeeze. This approval also validates the company's pipeline, particularly Tradipitant for GLP-1 induced nausea, which many believe positions Vanda as a strong takeover candidate.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending due to community bewilderment surrounding its bearish reaction to the Supreme Court's decision to strike down tariffs, a development widely anticipated as a significant positive given the company's prior reported tariff costs, fueling discussions of market manipulation.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is trending as the Supreme Court's ruling striking down Trump's "emergency" tariffs sparks intense community debate over potential financial repercussions and his defiant, immediate response to impose new, broader tariffs under different authorities.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

Crowdstrike is trending due to market reactions surrounding the release of Anthropic's Claude Code Security tool, which has prompted a re-evaluation of cybersecurity valuations with active community debate on its competitive impact and whether the stock is oversold.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR Protocol is gaining significant traction for its deep integration into the AI sector, including a partnership with NVIDIA, and its robust advancements in cross-chain interoperability with projects like Starknet. The community is actively discussing its "invisible engine" technology, rapid user growth, and strong potential in the anticipated altcoin season.

Figure Technology Solutions, Inc. is a blockchain-native capital marketplace, which engages in connecting origination, funding, and secondary market activity. It operates through the following segments: FTI, Markets, and Other. The FTI segment offers Figure Connect which generates ecosystem and technology fees, and originates, sells, and securitizes home equity line of credit (HELOC) loans that it services. The Markets segment utilizes blockchain technology to develop an exchange for digital assets and credit, with new product offerings including providing interest-bearing stable coin deposits. The company was founded by Michael Scott Cagney and June Ou in 2018 and is headquartered in Reno, NV.

Figure Technology Solutions Inc. - Ordinary Shares - Class A

Figure Technology Solutions Inc

Figure Technology Solutions is experiencing extreme volatility and a sharp price decline, igniting a fierce debate among investors. While many bulls view this as a generational buying opportunity for a fundamentally strong leader in blockchain-based lending and real-world asset tokenization, citing strong earnings guidance, a significant portion of the community dismisses it as a "pump and dump" scam, questioning its valuation amidst a broader unraveling of the blockchain RWA narrative ahead of its upcoming earnings report.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy ($SWEAT) is trending as the community debates its long-term potential and core move-to-earn utility, allowing users to earn tokens through physical activity. Despite current low prices and a lack of specific immediate news, many hope for its future recovery, while others remain skeptical about altcoins.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as community discussion focuses on its strategic exclusion from China's national drug list, aiming to preserve pricing power, while investors keenly await a pending U.S. Supreme Court decision on its patent infringement case. This coincides with anticipated positive financial results and ongoing speculation about a potential acquisition as the company positions for a turnaround.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

GEO Group is trending following contradictory reports on U.S. Immigration and Customs Enforcement's (ICE) future strategy, with news of reduced private facility reliance sparking a sell-off, clashing with discussions around robust new contracts and significant ICE expansion plans. This divergence has investors deeply split, with many seeing a deep value buying opportunity while others remain cautious of ongoing political headwinds.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler is heavily discussed due to recent AI disruption fears within the cybersecurity sector, sparked by Anthropic's Claude Code Security tool. The community is sharply divided, with some panicking over AI's potential to replace existing solutions, while others argue that robust platforms like Zscaler have strong moats and will integrate AI, viewing the current sell-off as an opportunity ahead of upcoming earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stoke Therapeutics (NASDAQ:STOK) Stock Price Up 10.2% - Here's Why

Stoke Therapeutics (NASDAQ:STOK) Stock Price Up 10.2% - Here's Why...

45,205 Shares in Stoke Therapeutics, Inc. $STOK Acquired by Principal Financial Group Inc.

Principal Financial Group Inc. bought a new position in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK - Free Report) in the third quarter, according to its most recent 13F filing with the...

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine and has a lead investigational...

Stoke Therapeutics spotlights durable Dravet gains, Phase 3 timeline, and new ADOA program at summit

Stoke Therapeutics (NASDAQ:STOK) used its presentation at the Guggenheim Emerging Outlook Biotech Summit 2026 to highlight long-term clinical findings for its lead program in Dravet syndrome, outline...

Stoke Therapeutics Announces First Patient Dosed in Phase 1 Study of STK-002, a Potential Disease-Modifying Medicine for the Treatment of Autosomal Dominant Optic Atrophy (ADOA)

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine, today announced that the first patient...

Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Stoke Therapeutics, Inc. (NASDAQ:STOK - Get Free Report) has been given an average rating of "Moderate Buy" by the eleven brokerages that are currently covering the stock, Marketbeat Ratings reports...

Guggenheim Upgrades Stoke Therapeutics (NASDAQ:STOK) to "Strong-Buy"

Guggenheim upgraded shares of Stoke Therapeutics to a "strong-buy" rating in a report on Thursday...

Penserra Capital Management LLC Acquires New Position in Stoke Therapeutics, Inc. $STOK

Penserra Capital Management LLC bought a new position in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK - Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC...

Stoke Therapeutics (NASDAQ:STOK) Trading 6.2% Higher - Here's What Happened

Stoke Therapeutics (NASDAQ:STOK) Trading Up 6.2% - Here's What Happened...

Stoke Therapeutics, Inc. $STOK is Skorpios Trust's Largest Position

Skorpios Trust lowered its holdings in Stoke Therapeutics, Inc. (NASDAQ:STOK - Free Report) by 30.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The...

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.

Current Price	$34.29
Prev Close	$34.37
Open	$34.26
Dividend Yield	0.00%
50-Day Moving Average	$31.69
Beta	1.31
Avg. Volume	758,015.20
PE Ratio	52.08

52-Week High	$38.69
52-Week Low	$5.35
Market Capitalization	$1.96B
EPS (Annual)	-$1.65
Price to Book	6.15
Revenue Per Employee	$285,585.94

STOK
Stoke Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest STOK News

STOKStoke Therapeutics Inc